Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
104,986,330
-
Number of holders
-
533
-
Total 13F shares, excl. options
-
72,453,964
-
Shares change
-
-208,717
-
Total reported value, excl. options
-
$25,316,735,783
-
Value change
-
-$80,452,734
-
Put/Call ratio
-
91%
-
Number of buys
-
267
-
Number of sells
-
-228
-
Price
-
$349.23
Significant Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q2 2016
631 filings reported holding REGN - REGENERON PHARMACEUTICALS, INC. - COMMON STOCK as of Q2 2016.
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) has 533 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 72,453,964 shares
of 104,986,330 outstanding shares and own 69.01% of the company stock.
Largest 10 shareholders include FMR LLC (9,416,836 shares), Capital World Investors (7,326,626 shares), WELLINGTON MANAGEMENT GROUP LLP (6,297,218 shares), VANGUARD GROUP INC (4,779,186 shares), STATE STREET CORP (3,093,295 shares), SANDS CAPITAL MANAGEMENT, LLC (2,659,741 shares), BlackRock Fund Advisors (2,221,959 shares), JENNISON ASSOCIATES LLC (2,030,925 shares), BlackRock Institutional Trust Company, N.A. (2,010,295 shares), and PRICE T ROWE ASSOCIATES INC /MD/ (1,815,993 shares).
This table shows the top 533 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.